Use of Cholecystokinin to Prevent the Development of Parenteral Nutrition‐Associated Cholestasis

Abstract

Levels of direct bilirubin were lower in the treated compared with the nontreated group. These findings suggest that cholecystokinin prophylaxis in high-risk neonates may help prevent the development of parenteral nutrition-associated cholestasis.